— Know what they know.
Not Investment Advice

MBOT NASDAQ

Microbot Medical Inc.
1W: -19.8% 1M: -19.1% 3M: -19.1% YTD: -17.5% 1Y: -36.5% 3Y: +45.0% 5Y: -73.3%
$1.74
+0.01 (+0.58%)
 
Weekly Expected Move ±9.1%
$2 $2 $2 $2 $2
NASDAQ · Healthcare · Medical - Instruments & Supplies · Alpha Radar Sell · Power 31 · $79.3M mcap · 46M float · 4.09% daily turnover · Short 44% of daily vol
Smart Money Score
Moderate 50
Insider
Congress
ETF Holdings
Key Statistics
Market Cap$79.3M
52W Range1.6-4.67
Volume1,366,218
Avg Volume1,863,586
Beta1.06
Dividend
Analyst Ratings
2 Buy 1 Hold 0 Sell
Consensus Buy
Company Info
CEOHarel Gadot
Employees20
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date1992-03-25
25 Recreation Park Drive
Hingham, MA 02043
US
781 875 3605
About Microbot Medical Inc.

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

Recent Insider Trades

NameTypeSharesPriceDate
Stockburger Aileen P A-Award 10,000 $2.37 2026-04-01
Madden Martin J. A-Award 10,000 $2.37 2026-04-01
Wenderow Tal Baruch A-Award 10,000 $2.37 2026-04-01
Wilson David James A-Award 10,000 $2.37 2026-04-01
Burell Scott R A-Award 10,000 $2.37 2026-04-01

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms